No black box warning on record for Xarah Fe

As of the latest FDA labeling reviewed, Xarah Fe (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE TABLETS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Xarah Fe medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS The use of combined oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the p

No black box warning on record for Xarah Fe

Other warnings & precautions

WARNINGS The use of combined oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the p

Xarah Fe Black Box Warning

No black box warning on record for Xarah Fe

Other warnings & precautions

Xarah Fe Black Box Warning

No black box warning on record for Xarah Fe

Other warnings & precautions